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Thirteen patients with stage I or II mycosis fungoides 
(MF) and 10 patients with large-plaque parapsoriasis en 
plaques (PEP) were examined for immunologic and cy-
togenetic disturbances. Total lymphocyte counts and im-
munoglobulin concentrations in the blood were normal. 
In vitro lymphocyte responses to polyclonal activators 
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and various antigens in standard concentrations were 
normal. However, titration of phytohemagglutinin and 
concanavalin A (ConA) disclosed significantly lowered 
responses to suboptimal concentrations in the patient 
group, most pronounced in patients with MF II. ConA-
induced leukocyte migration inhibitory factor (LIF) pro-
duction, tested in an indirect leukocyte migration inhib-
LPA: lymphocyte proliferation assay 
MF: mycosis fungoides 
MI: migration index 
PEP: parapsoriasis en plaques 
PHA: phytohemagglutinin-P 
PPD: purified protein derivative of tuberculin 
PWM: pokeweed mitogen 
SCE: sister chromatid exchange 
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itory assay, was low in the patient group. Furthermore 
spontaneous LIF production in vitro and small amounts 
of serum LIF were demonstrated in a few patients. The 
chromosomal banding pattern, sister chromatid ex-
change, and break frequency were within normal limits 
except for 3 translocations in the MF group. It is con-
cluded that even in early-stage MF a pathologic function 
of blood lymphocytes can be demonstrated, when sensi-
tive methods are applied. The findings might be impor-
tant for monitoring disease activity and effect of treat-
ment. 
The early stages of mycosis fungoides (MF) often follow a 
protracted course with no progression over years [1). Skin 
lesions may disappear following topical therapy (PUV A, elec-
tron-beam, and local nitrogen mustard) , and the induced re-
mission may last for varying periods of time [2-4]. Recently 
MF changes were found in the subcutaneous tissue below an 
epidermis/dermis apparently normalized during electron-beam 
therapy [5]. Since clinical evaluation of the skin seems insuf-
ficient regarding disease activity and since the course of MF in 
later stages is usually fatal, supplementary parameters for 
guiding the therapy would be desirable. 
The purpose of t he present study was to examine t he periph-
eral blood of patients with early-stage MF and of patients with 
parapsoriasis en plaques (PEP) to disclose changes in lympho-
cyte function and chromosome pattern that might be of value 
when evaluating disease activity and prognosis. 
MATERIALS AND METHODS 
Patients 
Patients with PEP and early-stage MF were included in the study if 
the disease activity during unaltered treatment, or without treatment, 
had been stable for at least 6 mont hs. Stability was defined as lack of 
clinical progression of t he cutaneous lesions, and no alterations of the 
histologic pattern. No patient receiving systemic chemotherapy or 
corticosteroids was accepted in the study. T he diagnosis of MF was 
based on t he clinical and histologic criteria set up by the Scandinavian 
Mycosis Fungoides Study Group [6]. PEP is classified by a combination 
of clinical and histologic findings [7], and only pat ients wit h t he la rge-
plaque variety were included. 
The distinction between PEP and MF II was made from both clinical 
and histologic criteria [6], whereas pat ients with MF I differed only 
clinically from patients with PEP, the histology being identical. Pa-
tients wi th PEP had from 1 to several well-demarcated patches meas-
uring more than 5 em with a wrinkled, poikilodermatous, slightly 
reddish-orange mottled surface. The skin lesions of patients with MF 
I consisted of erythematous well-demarcated, often irregularly circum-
scribed, slightly infi lt rated patches without poikilodermatous changes. 
The distribution of the skin lesions was the same in the PEP and MF 
I pat ients. 
Ten patients fulfilled t he diagnostic criteria of PEP and 13 those of 
MF. 
According to t he Scandinavian Mycosis Fungoides Study Group [6] 
the 13 patients belonging to the MF group were staged: MF I (erythem-
atous stage), 4 patients; MF II (plaque stage), 9 patients. The clinical 
data including the modality of treatment are shown in Table I. The 
extent of t he cutaneous involvement was recorded as percent of the 
total skin surface. Ext racutaneous manifestations of MF were excluded 
by lymph node palpation, lymphangiography, liver biopsy, bone marrow 
examination, and chest x-ray. 
Several skin biopsies were taken and were evaluated by the same 
pathologist. 
Quantitative determinations of immunoglobulins (rocket immunoe-
lectrophoresis), white blood cell and differential counts, thrombocyte 
counts , and concentrations of hemoglobin, LDH, and SGOT were 
performed by routine methods. 
Controls 
Lymphocyte proliferation assay was performed on 27 separate oc-
casions with a minimum interval of 1 week in 12 healthy persons. 
Thirteen patients with minor symptoms of no known relation to MF 
or PEP and with no apparent sign of immunologic disturbances served 
as matched controls in the leukocyte migration agarose inhibition test. 
TABLE I. Clinical data on 10 patients with parapsoriasis en plaques 
(PEP) and 13 patients with mycosis fungoides (MF) 
PEP MF I" MF II" 
n = 10 n = 4 n = 9 
Sex 
Female 3 3 4 
Male 7 1 5 
Age (years) 
Mean 58 61 61 
Range 31-75 21-83 25-83 
Mean durat ion of disease 6.6 7.0 12.1 
(years) 
Extent of cutaneous disease 
,;;;5% 8 4 9 
>5% 2 0 0 
Treatment 
PUVA 7 3 6 
Topical ni t rogen musta rd 0 0 1 
Otherb 3 1 2 
• Distinction between MF I and II is based on t he cri teria of the 
Scandinavian Mycosis Fungoides Study Group [6]. 
bOther treatment: x-ray, sunlamp. 
Controls in t he sister chromatid exchange (SCE) assay were matched 
as to smoking from a group of healt hy persons (since SCE is enhanced 
by smoking) . 
Lymphocyte Proliferation Assay (LPA) 
The techniques employed for lymphocyte stimulation in vit ro have 
been described in detail [8]. In brief, mononuclear cells were isolated 
by differential centrifugation on Isopaque-Ficoll , and, after washing, 
105 cells per vial were cul tured in triplicate in a medium conta ining 
15% pooled human serum. As polyclonal activators phytohemagglu-
t inin-P (PHA), concanavalin A (ConA) , and pokeweed mitogen (PWM) 
were employed; t hese cultures were incubated for 72 h. Using PHA and 
ConA, seria l dilutions of t he mitogens were employed, in order to 
quantify t he lymphocyte responses at suboptimal concentrations. The 
ant igens used were heat-killed Escherichia coli, an extract of Candida 
albicans, and purified protein derivative of tuberculin (PPD); these 
cultures were incubated for 120 h. Stimulation by antigens was not 
carried out in t he controls. ["C]Thymidine was added 24 h before the 
cells were harvested. The radioactivity incorporated was determined 
by liquid scint illation count ing. The values given a re median counts 
per min (cpm) , afte r subt raction of values in corresponding unstimu-
lated cul tures. 
Production of Leukocyte Migration Inhibitory Factor (L IF ) 
Mononuclear cells were obtained by dext ran sedimentation and 
subsequent Isopaque-Ficoll gradient centri fugation of heparinized 
blood as described by Beyum [9) . The cells were washed 3 t imes in 
Hanks' balanced salt solut ion and adjusted to 2.5 X 106 cells in 1 ml of 
medium TC-199, containing 25 mM HEPES buffer, 500 U/ml of 
penicillin, 500 llg/ ml of streptomycin, 20 U/ml of nystatin , and 10% 
(v/v) pooled, human AB serum. The cells were pulsed with 50 llg/ ml of 
ConA for 2 h at 37"C. After removing nonbound ConA by washing the 
cells 3 t imes, the cells were reincubated in medium supplemented with 
human AB serum for 21 h at 37"C. Supernatants were t hen collected 
by centrifugation and tested for LIF activity. Cont rol supernatants 
were obtained from cells treated in parallel but without exposure to 
Con A. 
Bioassay of LI F Activity 
An indirect leukocyte migration agarose technique (ILMAT) was 
employed using polymorphonuclear leukocytes from healt hy adul ts as 
indicator cells [10]. The cells, freed of contaminating erythrocytes by 
exposure to sterile water for 15 s, were t reated with 90 11l of LIF -rich 
or control supernatant for 1 h at 37"C. Then 10 Ill cell suspension was 
placed in wells cut in agarose, and t he agarose plates were incubated 
for 22 h at 37"C. A migration index (Ml) was determined by t he 
formula: 
mean migrat ion area of cells 
Ml = in LIF-rich supernatant 
mean migration area of cells 
in cont rol supernatant 
310 CLEMMENSEN ET AL 
To eliminate the possibility that a supernatant migration inhibitory 
activ ity was false ly attributed to LIF but in reality caused by residual 
ConA or other unrelated factors, the generation of LIF was always 
ascertained by the use of neutralizing anti-LIF antibody in parallel 
control experiments [11] . This rabbit anti -LIP-immunoglobulin was 
also used for the determination of spontaneous LIF production by 
nonstimulated lymphocytes, and for detection of free LIF in patient 
sera. A MI below 0.80 indicates spontaneous LIF production and free 
serum LIF. 
Cytogenetic Examinations 
Lymphocytes from patients with MF and PEP were stimulated with 
PHA and cultured for 72 h. Slides fo r chromosome analysis were stained 
with quinacrine mustard. The chromosomes in 100 metaphases from 
each of the patients were scored fo r banding pattern abnormalit ies and 
t he number of breaks was counted. The lymphocytes for SCE were 
cultured as mentioned, but with 5-bromo-2-deoxyuridine 6 !Lg/ml in 
the medium. The chromosome slides were treated with bisbenzimide, 
UV A illuminated, and Giemsa stained to differentiate sister chromatids 
[12]. T he number of SCE/cell was counted in 20- 30 cells; this part of 
the study comprised 7 PEP pat ients and 10 MF patients; and the 
results were compared to t he SCE counts in a corresponding number 
of control persons matched for tobacco consumption (see Table IV). 
For statistical evaluation, the Mann-Whitney rank sum test was 
applied. 
RESULTS 
All the patients with MF were in stage I or II, which means 
erythematous and plaque stage without extracutaneous involve-
ment . The mean duration of disease varied between the groups 
from 6.6 years (PEP) to 12.1 years (MF II) (Table I). The mean 
serum concentrations of IgG, IgA, and IgM were within normal 
limits, but elevated levels of IgG were found in 3 patients, of 
IgA in 7 patients, and of IgM in 4 patients with no apparent 
variation between disease groups .. 
T he mean absolute blood lymphocyte count was low: 1.54 X 
109/liter (range 0.59-2.9 X 109 ) varying from 1.13 X 109/ liter 
(MF I) to 1.76 X 109/ liter (PEP). The mean absolute polymor-
phonuclear count was 2.86 X 109/ liter. 
Neither t he blood lymphocyte count nor the levels of immu-
noglobulins were correlated to lymphocyte function (LPA, IL-
MAT) or to the duration or extent of the disease. 
The following tests were normal: hemoglobin concentration, 
thrombocyte count, LDH, alanin-amino-transferase, chest x-
ray, lymphangiography, and bone marrow examination. 
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Lymphocyte Proliferation 
The results of the LPA are given in Table II. The mean 
maximum stimulation by the 3 mitogens was lower in patients 
than in controls, but the differences were not statistically 
significant. Table II further shows the response to the mitogens 
in the various patient groups: the response to each mitogen was 
lowest in the MF II group and t he response in the whole MF 
group (MF I and II) was lower than the response in t he PEP 
patients and the controls. None of the differences is, however, 
statistically significant. The mean responses to t he ant igens 
were within normal ranges. The mean response to PPD in the 
MF II group was less than half of that observed in the MF I 
and PEP groups, but the difference is not statistically signifi-
cant (0.1 < p < 0.2) . 
The patterns of response following stimulation with serially 
diluted PHA and ConA are shown in Fig 1. 
In order to analyze the responses to suboptimal doses of PHA 
and ConA, these results were compared to the results obtained 
with concentrat ions of activators giving maximal response (Ta-
ble III). It is seen that the response to suboptimal concentra-
tions was significantly lower in the patients than in t he con-
trols, for both PHA and ConA. The most marked depression 
was found in the MF II patients, but the differences among 
patient groups were not significant. 
Production of LIF 
In t he whole patient group (MF and PEP) ConA-induced 
LIF production (ConA-LIF) was decreased (mean MI 0.82), 
and significantly lower than in the controls (mean MI 0.64) (p 
< 0.05; Fig 2). The mean MI showed only slight variation 
among the different disease groups. 
No consistent spontaneous product ion of LIF in vitro or 
serum LIF was found. In 3 patients, however, serum LIF was 
present, and 2 patients produced LIF spontaneously (in 1 of 
these patients serum LIF was detected). These findings were 
equally distributed among patient groups (Fig 2). In the controls 
neit her serum LIF nor spontaneous LIF production was ob-
served (data not shown ). 
No correlation between ConA-LIF and the extent of cuta-
neous involvement or mode of treatment was recognized. A 
positive linear correlation, however, between the duration of 
PEP and decreased ConA-LIF was found (Fig 3-correlation 
TABLE II. Lymphocyte proliferation assay in 23 patients with mycosis fungoides (MF) and parapsoriasis en plaques (PEP) 
All patients MF I + II MFI 
n = 23 n = 13 n =4 
PHA maxb 
mean cpm 18,425 17,967 22,217 
SEM ± 1,625 
ConA m ax.b 
mean cpm 13,717 13,685 17,213 
SEM ± 1,329 
PWM 
mean cpm 5,710 5,161 7,321 
SEM ± 695 
E. coli 
mean cpm 1,786 1,139 3,721 
SEM ± 450 
C. albicans 
mean cpm 1,284 1,660 3,853 
SEM ± 535 
PPD 
mean cpm 5,018 3,906 6,280 
Unstimulated 
SEM ± 1,121 
mean cpm 76 63 68 
SEM ± 12 
cpm =counts per min; n. t. = not tested. 
" Twenty-seven tests on separate days in 12 individuals. 
b T he maximum cpm was chosen irrespective of mitogen concentration. 
MFII PEP Controls 
n= 9 n = 10 n = 27" 
16,078 19,134 20,416 ± 1,330 
12,117 13,746 16,084 ± 1,074 
4,201 6,426 5,406 ± 425 
1,103 1,637 n.t. 
686 795 n.t. 
2,851 6,481 n.t. 
61 93 n.t. 
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cpm x 10-3 
20 
10 
...... 
PHA/ ConA concentration }Jg / ml 
F IG 1. Lymphocyte proliferation induced by seria lly diluted PHA 
a nd ConA in 23 patients with mycosis fungoides and parapsoriasis en 
plaques and in 27 cont rols (27 tests on separate days in 12 healt hy 
individuals) . cpm = Counts per minute; • = patients; 6 = controls; 
-- = PHA; --- = ConA. Vertical bars represent SEM. 
coefficient 0.82, p < 0.01) . No significant correlation between 
t hese parameters was found in either of the MF groups. There 
was no correlation between the age of the PEP patients and 
ConA-LIF. 
Cytogenetics 
The mean SCE and range for the patients and the matched 
controls is given in Table IV. No difference is seen . There was 
no difference in the number of hypomodal cells, breaks, or 
fragments. Three translocations were seen (14/ 15, 14/21, 4q+ ), 
1 in each of 3 patients with MF. 
TABLE III. Ratios between lymphocyte proliferation induced by 
polyclonal activators at one-eighth of maximum stimulating 
concentrations and at maximum stimulating concentrations 
( 
. cpm 1/8 max.) . . . . . 
ratw m patwnts wtth mycosts fungmdes (MF) and 
cpm max. 
parapsoriasis en plaques (PEP) compared with controls 
PHA Con A 
Mean Range Mean Range 
MF I 0.092 0.046- 0.130 0.320 0.100- 0.470 
(n = 4) 
MFII 0.102" 0.018- 0.390 0. 227b 0.160- 0.330 
(n = 9) 
PEP 0.147 0.019- 0.4 70 0.281 0.055- 0.480 
(n = 10) 
All patients 0.119" 0.018- 0.4 70 0.266b 0.055- 0.480 
(n = 23) 
Controls 0.211 0.043- 0.530 0.400 0.140- 0.730 
(n = 27) 
• p < 0.02 as compared to cont rols. 
b p < 0.01 as compared to controls. 
Ml Con A stimulated LIF Spontoreous LIF Serum LIF 
1.20 
100 
FIG 2. Leukocyte migration inhibi-
tory factor (LIF) in serum, spontaneous 
LIF production, and ConA-induced LIF 
production in patients wit h mycosis fun-
goides and parapsoriasis en plaques and 
healthy controls. MI =Migration inhib- o.so 
itory index; o =parapsoriasis en plaques; 
x = mycosis fungoides; 6 = healthy con-
trols. Horizontal bars indicate mean ± 
SD. Statistically significant differences 
between patients and controls are indi-
cated: § = p < 0.05; + = p < 0.01. 
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Ml 
0 
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0 10 15 
duration of PEP. years 
FIG 3. Correlation between migration index (ConA-induced LIF) 
and duration of disease in patients with parapsoriasis en plaques. Ml 
= migration index. MI/ duration of disease: correlation coefficient = 
0.82; p < 0.01. 
TABLE IV . Sister chromatid exchange (SCE) in patients with 
parapsoriasis en plaques (PEP), mycosis fungoides (MF), and matched 
controls (SCE were counted in 20- 30 cells in each patient/control) 
PEP 
Controls 
MF 
Controls 
No. of patients/ SCE/ce ll 
controls 
7 
7 
10 
10 
DISCUSSION 
Mean Range 
8.22 7.25-9.15 
8.27 7.03- 8.90 
7.83 6.90- 9.64 
8.02 6.57- 9.43 
Earlier studies of blood lymphocytes in patients with MF 
with regard to their number, morphology, subpopulations, cyto-
genetics, and function have demonstrated abnormalities only 
in the later stages (III and IV) [13], where the prognosis already 
is dubious [1 ,14). Therefore the purpose of the present study 
was to investigate the quantity, function, and chromosomal 
pattern of blood lymphocytes from patients with early-stage 
MF (I and II), and from patients with PEP of the large-plaque 
variety carrying the potential of progression to MF, in order to 
find in vitro parameters of lymphocyte abnormalities, which 
might be of diagnostic aid and therapeutic guidance. At t he 
moment, therapy is guided by clinical and histologic findings 
alone. 
Chromosome studies have been performed after a culturing 
period of 72 h. This culture period was chosen because it would 
make possible a comparison between the conventional chro-
mosome analysis and the SCE analysis. SCE can be visualized 
only after 2 rounds of replication, therefore a 72-h culturing 
period was used. The culture period may be of importance for 
the number of aberrations found. Results from studies of lead-
exposed workers [15,16) indicate an increase in the rate of 
chromosome aberrations with prolonged culture time (50- 72 
h) . In the 1978 ISCN (17] no guidelines are given. 
Several chromosome studies have been performed [18- 20], 
and aberrations in chromosome number as well as morphology 
have been demonstrated in the later MF stages. 
We found translocations in 3 patients with early stages of 
MF, but otherwise the chromosome complement was normaL 
The normal break and SCE frequencies indicate that no 
severe infection or exogenous mutagenic influence has been 
present. Quantitation of SCE is considered a sensitive method 
for detecting the influence of mutagens or carcinogens [21). 
We found a low-normal mean lymphocyte count. This is in 
accordance with the findings of MacKie [22) . She further 
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studied lymphocyte subpopulations and found normal B-, de-
creased T-, and increased null-cell counts (rosetting technique, 
E- and EAC-rosettes) in patients of probably stage II and later. 
The maximum proliferative lymphocyte responses in vitro to 
polyclonal activators were somewhat, but not significantly, 
lower in patients than in controls. It has been shown that 
titration curves of various mitogens will disclose more subtle 
aberrations of lymphocyte function than stimulation by single 
mitogen concentration [23). When suboptional concentrations 
of mitogens were employed, we found significant reduction of 
thymidine incorporation as compared to the maximal response 
(Table III) , which suggests a functional lymphocyte defect even 
at this early stage of disease. It must be recognized that reduced 
thymidine incorporation in vitro does not necessarily reflect 
decreased cell proliferation [24). In previous studies the lym-
phocyte response to various mitogens has been found to be 
depressed [25,26], but only in MF stages III and IV. Du Vivier 
[27) made PHA titration curves in patients with MF and found 
the most reduced responses to suboptimal concentrations of 
PHA. Only 3 MF I-II patients were included in his study, but 
the titration curve of these patients seems to be shaped like the 
patient curves in the present study. 
Con A-induced LIF production (ConA-LIF) is decreased in 
diseases involving the lymphocytes such as chronic lymphocytic 
leukemia and infectious mononucleosis [28,29). The response 
does not invariably run parallel with the proliferation response 
of lymphocytes to mitogens [30). In addition to decreased 
ConA-LIF, Palit eta! [29) found increased LIF production in 
apparently unstimulated lymphocyte cultures, and also in-
creased amounts of LIF in serum from patients with active 
infectious mononucleosis. Our findings are much like those 
found in the convalescence phase of mononucleosis, that is, low 
ConA-LIF and, in a few patients, spontaneous LIF production 
and measurable serum LIF. The rarity of the latter discrete 
findings is in accordance with that ·of Thulin (31) who found 
no serum LIF in 13 patients with MF. 
Gorski [32) found low levels of LIF production in one way 
mixed lymphocyte culture and low ConA-LIF in 4 and 2 pa-
tients, respectively, out of 10 with MF, but the disease stage 
was not specified. Another related lymphokine, macrophage 
migration inhibitory factor, was released spontaneously by 
cultured lymphocytes in all of 6 patients with Sezary's syn-
drome [33], considered the leukemic variant of MF, but only in 
minute amounts in 1 of 10 patients with various extensive 
chronic skin diseases, indicating that unspecific dermatitis per 
se is not accompanied by lymphokine production. This finding 
is important since PEP and MF I clinically can mimic "unspe-
cific dermatitis." The cause of the diminished proliferation and 
decreased capacity of LIF production of the patients' lympho-
cytes is not disclosed in the present study. Possible explana-
tions include suppressor/cytotoxic T -cell activities in the more 
advanced disease stages, or the presence of circulating, func-
tionally deficient malignant cells contributing to the dimin-
ished lymphocyte responses by "simple dilution." 
We found a positive linear correlation between the duration 
of disease and depressed ConA-LIF in patients with PEP. This 
is in agreement with the hypothesis of antigenic persistence as 
a pathogenetic factor in MF [34,35], suggesting a correlation 
between the degree of abnormality of the lymphocytes and the 
duration of antigenic stimulation. 
We conclude that even in early MF and PEP blood lympho-
cytes are functionally abnormal and, although only discrete 
changes were found in some of the parameters studied, titration 
curves of LP A and ConA-LIF determinations might be valuable 
for monitoring disease activity with special reference to treat-
ment. 
REFERENCES 
1. Epstein EH, Levin DL, Croft JD, Lutzner MA: Mycosis fungoides. 
Survival, prognostic features, response to therapy and autopsy 
findin gs. Medicine (Baltimore) 15:61- 72, 1972 
Oct. 1983 LYMPHOCYTE FUNCTION AND CHROMOSOME ABERRATIONS 313 
2. Van Scott EJ, Ka lmanson JD: Complete remissions of mycosis 
fungoides lymphoma induced by topical ni trogen mustard 
(HN2). Cancer 32:18-30, 1973 
3. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick 
TB: Oral methoxsalen photochemotherapy of mycosis fungo ides. 
Cancer 38:683-689, 1976 
4. Fuks Z, Hoppe RT, Bagshaw MA: The role of total skin irradiation 
with electrons in the management of mycosis fungoides. Bull 
Cancer (Paris) 64:291-304, 1977 
5. Proctor MS, Price NM, Cox AJ , Hoppe TR: Subcutaneous mycosis 
fungoides. Arch Dermatol 114:1326- 1328, 1978 
6. Molin L , Thomsen K , Volden G, Groth 0 : Photochemotherapy 
(PUV A) in the pretumour stage of mycosis fungo ides: a report 
from the Scandinavian mycosis fungoides study group. Acta 
Derm Venereol (Stockh) 61:47-51, 1980 
7. Lambert WC: Parapsoriasis, Dermatology in General Medicine, 
2nd ed. Edited by TB Fitzpatrick, AZ Eisen, K Wolff, IM 
Freedberg, KF Austen. New York, McGraw-Hill , 1979, pp 808-
817 
8. Andersen V, Thomsen M, Cohn J: Immune deficiency in sex-linked 
hereditary t hrombocytopenia. Acta Pathol Microbiol Scand [C] 
83:177-183, 1975 
9. Beyum A: Isolation of lymphocytes, granulocytes a nd macrophages. 
Scand J lmmunol [Suppl] 5:9- 15, 1976 
10. Bendtzen K : Determination of t he human lymphokine leukocyte 
migration inhibitory factor (LIF) by a sensitive radioenzymatic 
assay. Inhibitory effect of cGMP on t he esterolytic activity of 
highly purified LIF. J Clin Lab lmmunol 2:37- 43, 1979 
11. Bendtzen K: The production of heterologous antibodies to the 
human lymphokine: leukocyte migration inhibi to ry factor (LIF) . 
Cell Immunol 29:382-393, 1977 
12. Wulf HC: Modified method fo r demonstrating .sister chromatid 
exchange (SCE). Dan Med Bull 27:35-37, 1980 
13. Zackheim HS: Cutaneous T -cell lymphomas. a review of t he recent 
literature. Arch Dermatol 117:295-304, 1981 
14. Lamberg SI, Green SB, Byar DP, Block JB, Clendenning WE, 
Epstein EH, Fuks ZY, Golits LE, Lorencz AL, Michel B, Roegnik 
HH, Van Scott EJ, Vonderheld EC, Thomas RJ: Status report 
of 376 mycosis fungoides patients at 4 years: mycosis fungoides 
cooperative group. Cancer Treat Rep 63:701- 707, 1979 
15. Forni A, Sciame A, Bertazzi PA, Alessio L: Chromosome and 
biochemical studies in women occupationally exposed to lead. 
Arch Environ Health 35:139-145, 1980 
16. Mii.ki-Paakkanen J , Sorsa M, Vainio H: Chromosome aberrations 
and sister chromatid exchanges in lead-exposed workers. Here-
ditas 94:269-275, 1981 
17. ISCN: An international system for human cytogenetic nomencla-
ture. Cytogenet Cell Genet 21:363- 373, 1978 
18. 
19. 
20. 
21. 
22. 
23. 
24 . 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
Erkman-Balis B, Rappaport H: Cytogenetic studies in mycosis 
fungoides. Cancer 34:626- 633, 1974 
Edelson RL, Berger CL, Raafat J, Wa rburtun D: Karyotype studies 
of cutaneous T cell lymphoma: evidence for clonal origin. J 
Invest Dermatol 73:548-550, 1979 
Van Vloten WA, Pet EA, Geraedts JPM: Chromosome studies in 
mycosis fungoides. Br J Dermatol 102:507- 513, 1980 
Perry P, Evans HJ : Cytological detection of mutagen-carcinogen 
exposure by s ister chromatid exchange. Nature 258:121- 125, 
1975 
MacKie R, Siess FR, Cochran R, de Sousa M: Lymphocyte abnor-
malit ies in mycosis fungoides. Br J Dermatol 94:173-178, 1976 
Hosking CS, Fitzgerald MG, Simons MJ: Quantified deficiency of 
lymphocyte response to phytohaemagglutinin in immune defi-
ciency diseases. Clin Exp lmmunol 9:467- 476, 1971 
Maurer HR: Potential pitfalls of [3H] t hymidine techniques to 
measure cell proliferation. Cell Tissue Kinet 14:111-120, 1981 
Langner A, Glinski W, P awinska M, Obalek S: Lymphocyte t ra ns-
formation in mycosis fungoides. Arch Dermatol Forsch 251:249-
257, 1975 
Cooperrider PA, Roegnik HH: Selective immunological evaluation 
of mycosis fungoides. Arch Dermatol 114:207- 212, 1978 
du Vivier A, Harper RA, VonderheidE, Van Scott EJ: Lymphocyte 
transformation in patients with stages mycosis fungoides and 
Sezar,y syndrome. Cancer 42:209-213, 1978 
Cohen S, Fisher B, Yoshida T , Bettigole RE: Serum migration -
inhibitory activity in patients with lymphoproliferative diseases. 
N Eng! J Med 290:882-886, 1974 
Pali t J, Bendtzen K, Andersen V: Production of leukocyte migra-
tion inhibition factor (LIF) in in fectious mononucleosis. Clin 
Exp lmmunol 31:66- 71, 1978 
Rocklin RE, Bendtzen K, Greineder D: Mediators of immunity: 
lymphokines and monokines. Adv lmmunol 29:55- 136, 1980 
Thulin H: Absence of leukocyte-migration inhibitory factor in 
serum from patients with mycosis fungoides. Arch Dermatol Res 
257:157-161, 1976 . 
Gorski AJ , Dupont B, Hansen JA, Safai B, Pahwa S, Good RA: 
Human immunodeficiency disease: impairment of cellular inter-
actions leading to abnormal mediator production in mi xed lym-
phocyte culture reaction. J lmmunol 118:858- 862, 1977 
Yoshida T, Edelson R, Cohen S, Green 1: Migration inhibitory 
activity in serum and cell supernatants in patients with Sezary 
syndrome. J Immunol 114:915- 918, 1975 
T an RS-H , Butterworth CM, McLaughlin H, Maika S, Samman 
PD: Mycosis fungoides-a disease of antigen persistence., Br J 
Dermatol 91:607- 616, 1974 
Rowden G, Lewis MG : Langerhans cells: involvement in t he path-
ogenesis of mycosis fungoides. Br J Derma to! 95:665- 672, 1976 
